multicenter dose escalation

Related by string. * Multicenter : multicenter Phase II . multicenter randomized double . Multicenter Randomized Double . multicenter randomized / DO Se . DOSE . Doses . DOSES : mg kg dose . tolerated dose MTD . multiple ascending dose . priming doses / escalations . Escalations . ESCALATION . Escalation : label dose escalation . dose escalation study . dose escalation . dose escalation trial * *

Related by context. Frequent words. (Click for all words.) 62 forodesine 62 Phase Ib clinical 61 Initiate Phase 61 phase IIb clinical 61 IIa trial 61 placebo controlled Phase 61 multicenter Phase 61 label multicenter 61 double blinded placebo 59 Pivotal Phase 59 MKC# 59 phase IIa 59 Phase 1b 59 blinded placebo controlled 59 Pivotal Phase III 59 Phase Ib 59 dose escalation trial 58 Tesetaxel 58 R sorafenib tablets 58 Phase 2b clinical 58 Cetrorelix 58 Phase II 58 Panzem R 58 Phase 1a 58 INCB# [001] 58 REOLYSIN ® 58 phase IIa clinical 58 Phase IIIb 58 randomized multicenter 57 StemEx 57 Phase 1b clinical 57 BAY #-# 57 BMS # 57 TYGACIL 57 SCH # 57 pertuzumab 57 phase 2a 56 Urocidin 56 liposomal formulation 56 phase IIb 56 APTIVUS 56 custirsen 56 confirmatory Phase III 56 dose escalation 56 deforolimus 56 HGS ETR1 56 Phase 2b study 56 Imprime PGG 56 IMC A# 56 prospective multicenter 56 multicenter randomized 56 Allovectin 7 R 56 ixabepilone 56 Phase III 55 GLPG# 55 CORT # 55 subcutaneous formulation 55 Cloretazine R VNP#M 55 pharmacokinetics PK 55 optical biosensors 55 valopicitabine 55 ZD# [001] 55 Phase 2b clinical trials 55 #mg/day [001] 55 pharmacodynamic effects 55 registrational trial 55 Phase III Clinical Trial 55 celgosivir 55 6R BH4 55 Ixempra 55 Mipomersen 55 angiogenesis inhibitor 55 Azedra 55 rNAPc2 55 interferon beta 1b 55 Clevudine 55 vascular disrupting agent 55 Phase 2a clinical 55 Phase 2a 55 OXi# 55 mg QD 55 Phase III randomized 55 Phase 2a trial 55 Phenoptin 55 randomized Phase III 55 direct thrombin inhibitor 55 thymalfasin 54 Phase IIB 54 multi kinase inhibitor 54 Amrubicin 54 administered subcutaneously 54 Irinotecan 54 Traficet EN 54 AeroLEF TM 54 placebo controlled randomized 54 bicifadine 54 Phase Ia 54 Pirfenidone 54 Phase IIb trials 54 IMC #B 54 nonrandomized

Back to home page